Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Delacroix-Chevalier is a French surgical-instrument brand focused on cardiovascular and thoracic surgery. The business manufactures reusable surgical instruments and retractors used by cardiothoracic surgeons, including products for minimally invasive and open procedures. Its portfolio emphasizes precision instrumentation such as forceps, scissors, needle holders, clamps, and specialized retractors, and it has highlighted Datamatrix-based traceability across instruments. Delacroix-Chevalier originated as an independent company and was integrated into Landanger in 2005, where it now operates as a specialized product line/brand within Landanger's broader surgical instrumentation business. The company is healthcare-related, but it is not a drug-development biotech or pharma company; it is a commercial-stage medical-device instrumentation business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Delacroix-Chevalier.